v3.26.1
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 09, 2026
Apr. 20, 2026
Apr. 05, 2026
Mar. 30, 2026
Jan. 30, 2026
Jan. 27, 2026
Jan. 14, 2026
Jan. 05, 2026
Jun. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Apr. 16, 2026
Feb. 19, 2026
Dec. 31, 2025
Subsidiary, Sale of Stock [Line Items]                                
Proceeds from stock options exercised                   $ 561,808   $ 561,808        
Proceeds from exercise of stock options, net of subscription receivable                       533,924      
Subscription receivable                 $ 27,884 27,884   27,884      
Refund payable - cancelled stock option exercise                 $ 43,125 $ 43,125   $ 43,125      
Number of shares issued                       2,268,204        
Gross proceeds received                       $ 1,637,004      
Subscription per price                 $ 4.00 $ 4.00   $ 4.00        
Rights offering subscription proceeds in escrow                 $ 113,003 $ 113,003   $ 113,003 $ 6,704,304     6,704,304
Antidilutive shares                   11,416,410   11,416,410        
Share-Based Payment Arrangement, Option [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Antidilutive shares                   1,682,500   1,682,500        
Warrant [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Antidilutive shares                   30,000   30,000        
Series A Right [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Antidilutive shares                   4,498,204   4,498,204        
Series B Right [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Antidilutive shares                   4,498,204   4,498,204        
Restricted Stock Units And Restricted Stock Awards [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Antidilutive shares                   707,502   707,502        
Rights Offering [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Gross proceeds from subscription             $ 9,072,816                  
Units description             each Unit consisting of one share of common stock, one Series A Right to purchase one share of common stock at $5.00 per share (expiring July 18, 2026), and one Series B Right to purchase one share of common stock at $6.00 per share (expiring November 20, 2026)                  
Funds received in escrow                               6,704,304
Gross proceeds received                     $ 2,368,512          
Issuance costs                     $ 1,009,318          
Deferred offering costs                               $ 164,807
Net proceeds                       $ 8,063,498        
Rights Offering [Member] | Series A Right [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share price             $ 5.00                  
Rights Offering [Member] | Series B Right [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share price             $ 6.00                  
Rights Offering [Member] | Basic Subscriptions [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Subscription rights             1,247,086                  
Rights Offering [Member] | Over-Subscriptions [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Subscription rights             1,021,118                  
Registered Direct Offering [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Units description           Unit consisting of one share of common stock, one Series A Right to purchase one share of common stock at $5.00 per share (expiring July 18, 2026), and one Series B Right to purchase one share of common stock at $6.00 per share (expiring November 20, 2026)                    
Net proceeds           $ 8,323,748                    
Number of units issued           2,230,000                    
Unit price per share           $ 4.055                    
Gross proceeds from offering           $ 9,042,650                    
Issuance costs           718,902                    
Accountable expense           $ 15,000                    
Registered Direct Offering [Member] | Series A Right [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share price           $ 5.00                    
Registered Direct Offering [Member] | Series B Right [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Share price           $ 6.00                    
Consulting Agreement [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock price $ 6.84                              
Number of shares issuable 800,002                              
Number of shares issued                 100,000              
Stock to be issued description The remaining 700,002 shares of common stock will be issued in nine equal monthly installments of 77,778 shares commencing in October 2026,subject to continued services.                              
Aggregate grant-date fair value of award $ 5,472,014                              
Employees [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of stock options exercised                 197,800              
Proceeds from stock options exercised                 $ 561,808              
Proceeds from exercise of stock options, net of subscription receivable                 533,924              
Subscription receivable                 $ 27,884 $ 27,884   27,884        
Employees [Member] | Minimum [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Exercise price per share                 $ 1.02              
Employees [Member] | Maximum [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Exercise price per share                 $ 3.88              
Holder [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of stock options exercised                 25,000              
Refund payable - cancelled stock option exercise                 $ 43,125 43,125   43,125        
Restricted Stock Units And Restricted Stock Awards [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock-based compensation expense                   727,638   $ 1,210,064        
Weighted-average remaining contractual life                       11 months 8 days        
Unrecognized compensation cost                 4,802,700 4,802,700   $ 4,802,700        
Aggregate intrinsic value                 $ 4,924,214 4,924,214   $ 4,924,214        
Restricted Stock Units And Restricted Stock Awards [Member] | Consulting Agreement [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of shares issuable 800,002                              
Number of shares issued                 100,000              
Stock to be issued description the remaining balance of 700,002 shares of common stock will be issued in monthly installments of 77,778 commencing in October 2026 for continued services                              
Share-Based Payment Arrangement, Option [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of stock options exercised                       197,800        
Exercise price per share                       $ 2.84        
Number of options granted                       664,800        
Stock-based compensation expense                   192,238   $ 342,422        
Unrecognized compensation cost                 $ 2,017,943 2,017,943   $ 2,017,943        
Compensation expense recognition period                       3 years 7 months 2 days        
Weighted-average remaining contractual life                       5 years 6 months 21 days        
Intrinsic value                 7,622,297 7,622,297   $ 7,622,297        
Warrant [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock-based compensation expense                   0   0        
Warrants outstanding                           1,900,500 1,366,442  
Exercise price per share                           $ 8.48 $ 7.00  
Unrecognized compensation cost                 0 0   $ 0        
Weighted average remaining contractual life                       2 months 19 days        
Intrinsic value                 $ 13,193,556 $ 13,193,556   $ 13,193,556        
2020 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of RSU issued   15,000                            
Stock price   $ 2.00                            
2020 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member] | Board Advisor [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of RSU issued               15,000                
Stock price               $ 3.65                
Vested shares     3,750         3,750                
2020 Equity Incentive Plan [Member] | Restricted Stock [Member] | Officers [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of RSU issued         150,000                      
Value of awards granted         $ 456,000                      
2020 Equity Incentive Plan [Member] | Restricted Stock [Member] | Each Officer [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of RSU issued         50,000                      
2020 Equity Incentive Plan [Member] | Restricted Stock [Member] | Officer [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Number of RSU issued         150,000                      
Stock price   $ 3.04                            
2020 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]                                
Subsidiary, Sale of Stock [Line Items]                                
Stock price       $ 1.76 $ 3.04                      
Common stock available for future issuance                 5,343,425 5,343,425   5,343,425        
Number of options granted       64,800 200,000                      
Options vesting condition         The options shall be subject to service-based vesting with twenty-five percent (25%) of the shares underlying the option vesting on the first anniversary of the date of grant and the remaining seventy-five percent (75%) vesting in thirty-six (36) equal monthly installments if the executive remains in continuous employment or service with the Company on each applicable vesting date                      
Estimated fair value market       $ 98,500 $ 1,644,300                      
Expected term       6 years 3 days 7 years 3 days                      
Exercise price       $ 1.76 $ 3.04                      
Volatility       116.20% 119.50%                      
Risk-free rate       4.07% 4.01%                      
Exercise price per share       $ 1.76